XYRATEX LTDNOTES TO AUDITED CONSOLIDATED FINANCIAL STATEMENTS (Continued)(U.S. dollars and amounts in thousands, except per share data, unless otherwise stated)13. Financial Instruments (Continued)November 30, 2005 and November 30, 2004, respectively. Any remaining unrealized amounts areexpected to be reclassified to earnings during the next twelve months. The fair value of these foreigncurrency contracts represents the amount the Company would receive or pay to terminate the contracts,considering first, quoted market prices of comparable agreements, or in the absence of quoted marketprices, such factors as interest rates, currency exchange rates and remaining maturity.The following table shows derivatives existing as of November 30, 2005 and November 30, 2004:November 30,2005 2004Forward exchange contracts and options .................. $46,070 $21,127Fair value of contracts—asset (liability) ................... $(1,658) $ 1,348Carrying value of contracts—asset (liability) ................ $(1,658) $ 1,348Average rate of contract .............................. $ 1.84 $ 1.76Period end rate .................................... $ 1.72 $ 1.89Maximum period of contracts (months) ................... 12 12Fair valuesThe carrying values of all financial instruments, including forward foreign exchange contracts,approximate their fair values.14. Commitments and ContingenciesOperating Lease Commitments: The Company leases certain real and personal property from bothunrelated third parties and HIL a related party (see Note 17). Future minimum lease payments undernon-cancelable operating leases agreements as of November 30, 2005 are as follows:Related party Other TotalYear Ending November 30:2006 ................................... $ 3,487 $2,763 $ 6,2502007 ................................... 3,479 1,842 5,3212008 ................................... 3,487 842 4,3292009 ................................... 3,224 624 3,8482010 and thereafter ........................ 995 367 1,362Total minimum payments required ............ $14,672 $6,438 $21,110Certain leases require the Company to pay property taxes, insurance and routine maintenance.Rent expense was $5,592, $4,273 and $3,649 for the years ended November 30, 2005, 2004 and 2003,respectively. These expenses include $3,319, $2,974 and $2,140 for the years ended November 30, 2005,2004 and 2003, respectively to a related party (Note 17).Customer Indemnity. As an element of standard customer contracts, the Company includes certainclauses that indemnify the customer against liability and damages, including legal defense costs, whichF-36
XYRATEX LTDNOTES TO AUDITED CONSOLIDATED FINANCIAL STATEMENTS (Continued)(U.S. dollars and amounts in thousands, except per share data, unless otherwise stated)14. Commitments and Contingencies (Continued)might arise from claims of patent, copyright, trademark or trade secret infringement by the productsmanufactured by the Company.Contingencies. The Company is involved in lawsuits, claims, investigations and proceedings,including patent and commercial matters that arise in the ordinary course of business. There are nosuch matters pending that the Company expects to be material in relation to its business, consolidatedfinancial position, results of operations or cash flows.Product warranty. The following table provides the changes in the product warranty accrual forthe years ended November 30, 2004 and 2005:Amount ofliabilityBalance at November 30, 2003: ................................ $1,231Acquisition of businesses .................................... 508Accruals for warranties issued during the year ..................... 1,561Settlements made during the year .............................. (1,381)Balance at November 30, 2004: ................................ $1,919Acquisition of businesses .................................... 303Accruals for warranties issued during the year ..................... 2,046Settlements made during the year .............................. (1,723)Balance at November 30, 2005: ................................ $2,54515. Supplemental Cash Flow InformationCash paid for income taxes was $1,733 and cash received was $1,407 for the year endedNovember 30, 2005. Cash paid for income taxes was $1,323 and $3,362 for the years endedNovember 30, 2004 and 2003 respectively. Cash paid for interest was $450, $467 and $725 for the yearsended November 30, 2005, 2004 and 2003, respectively.Non cash investing and financing activities included the recording of an acquisition note payable of$3,000 in connection with the acquisition of Oliver Design during 2005.16. Segment InformationDescription of segments. The Company designs, develops and manufactures enabling technology insupport of high-performance storage and data communication networks. The Company organizes itsbusiness operations into two product groups—Storage & Network Systems and Storage Infrastructure,each of which comprises a reportable segment.Description of the Company’s segments:Storage & Network Systems. Provision of high performance, high density, network storagesubsystem technology to OEMs supplying the network storage and data networking market places.F-37
- Page 3:
XYRATEX LTDANNUAL REPORT FOR THE YE
- Page 6 and 7:
INTRODUCTIONWe are incorporated und
- Page 8 and 9:
Year Ended November 30,2005 2004 20
- Page 10 and 11:
The computations for the weighted a
- Page 12 and 13:
The markets in which we operate are
- Page 14 and 15:
technological capabilities. This co
- Page 16 and 17:
may cease production of components,
- Page 18 and 19:
• potentially adverse tax consequ
- Page 20 and 21:
We could incur substantial costs, i
- Page 22 and 23:
influence by voting at a meeting of
- Page 24 and 25:
Xyratex Ltd to the former sharehold
- Page 26 and 27:
In addition to the rapid growth of
- Page 28 and 29:
RAID controller technology is proje
- Page 30 and 31:
Our Competitive StrengthsDisk drive
- Page 32 and 33:
the storage subsystem and disk driv
- Page 34 and 35:
Our storage subsystems are internal
- Page 36 and 37:
systems are capable of testing a fu
- Page 38 and 39:
Research and DevelopmentWe have ove
- Page 40 and 41:
• sets forth procedures for the p
- Page 42 and 43:
Item 4C: Organization StructureXyra
- Page 44 and 45:
ecame the parent company of our bus
- Page 46 and 47:
Foreign Exchange Rate FluctuationsT
- Page 48 and 49:
we recorded in the year ended Novem
- Page 50 and 51:
Fiscal Year Ended November 30, 2005
- Page 52 and 53:
Research and Development—otherThe
- Page 54 and 55:
Fiscal Year Ended November 30, 2004
- Page 56 and 57:
Selling, General and Administrative
- Page 58 and 59:
Quarterly Results of OperationsThe
- Page 60 and 61:
sales growth. The increase in defer
- Page 62 and 63:
choose to make or alliances we have
- Page 64 and 65:
compete. Identifiable intangible as
- Page 66 and 67:
ITEM 6: DIRECTORS, SENIOR MANAGEMEN
- Page 68 and 69:
Ernest Sampias has served as a dire
- Page 70 and 71:
Audit CommitteeOur Audit Committee
- Page 72 and 73:
Employee Benefit/Share Option Plans
- Page 74 and 75:
The maximum amount that any partici
- Page 76 and 77: Restricted StockRestricted stock aw
- Page 78 and 79: the options, warrants or rights, bu
- Page 80 and 81: Quarterly high and low market price
- Page 82 and 83: whose functional currency is not th
- Page 84 and 85: on the Nasdaq National Market and,
- Page 86 and 87: Interest RatesWe had cash and cash
- Page 88 and 89: aggregate in any fiscal year and th
- Page 90 and 91: (This page has been left blank inte
- Page 92 and 93: XYRATEX LTDAUDITED CONSOLIDATED BAL
- Page 94 and 95: F-4XYRATEX LTDAUDITED CONSOLIDATED
- Page 96 and 97: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 98 and 99: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 100 and 101: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 102 and 103: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 104 and 105: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 106 and 107: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 108 and 109: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 110 and 111: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 112 and 113: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 114 and 115: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 116 and 117: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 118 and 119: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 120 and 121: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 122 and 123: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 124 and 125: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 128 and 129: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 130: (This page has been left blank inte